Loading Page..

Knowledge Content Library

206
How to win friends and influence deal terms
Presented by Ajoy Chakrabarti (BristolMyersSquibb) at 2005 DAAG Conference in Philadelphia. Discussion of licensing problem for an oncology drug.

207
Modeling the global latent therapeutic demand for hemophilia A
Presented by Jeff Stonebreaker (GlaxoSmithKline) and Donald Keefer (Arizona State University) at 2005 DAAG Conference in Philadelphia. Shows model based on probability-encoding principles and discrete approximation techniques to estimate global latent therapeutic demand for hemophilia A using population-based epidemiology and treatment modalities.

208
Partition Dependence and Subjective Probabilities: Problem and Solution
Presented by Bob Clemen (Duke University) with Craig Fox and Canan Ulu at 2005 DAAG Conference in Philadelphia. Discusses various cognitive biases and innovative ways to minimize their occurrence and impacts.

209
Portfolio Management at HP
Presented by Michael Menke at 2005 DAAG Conference in Philadelphia. Portfolio management at HP, including nice overview of PM in general and in other companies.

210
Scenario-Based Project Planning
Presented by Frank Miller (Rohm and Haas) at 2005 DAAG Conference in Philadelphia. Overview of project planning using FIATECH (Fully Integrated and Automated TECHnology for the capital facilites industry).

211
Texas Hold ‘Em (DA Approaches to IT)
Presented by Jim Weller (Chevron) and Jerry Lieberman (Decision Strategies) at 2005 DAAG Conference in Philadelphia. Discussion of ways to value IT investments in an organization.

141
Incorporating Learning Models in Structuring and Valuing R&D Projects
Presented by Phil Beccue (Baxter) at 2004 DAAG Conference in San Francisco. Real options example using decision trees for evaluation of "learning models".

142
Back of the Envelope Analysis
Presented by Harry Eckerson and David Swank (GlaxoSmithKline) at 2004 DAAG Conference in San Francisco. Example of how to do a quick analysis when time is insufficient for more detailed work, using sensitivity and what-if analyses.

143
Can We Agree to Disagree? Organizational Complexity in Decision Making
Presented by Ronald Allred (ConocoPhillips) at 2004 DAAG Conference in San Francisco. Discussion of organizational complexity, team dynamics, and the use of Decision Coaching to resolve issues and improve team performance.

144
Convince Me Your Complex Analysis is Correct
Presented by Gary Hagstrom (Chevron) at 2004 DAAG Conference in San Francisco. Questions to ask to identify whether a decision analysis has been done well, and the interaction between analytical quality and salesmanship.

145
Decision Analysis to Evaluate Clinical Proof-of-Principle Trial Design for a New Drug
Presented by Vish Viswanathan and Rick Bayney (Johnson & Johnson) at 2004 DAAG Conference in San Francisco. Example of value of information approach to evaluation of a trial design decision.

146
Development of a Portfolio Process at ChevronTexaco Overseas Petroleum
Presented by Tony Kenck (Chevron) at 2004 DAAG Conference in San Francisco. Portfolio planning process in Chevron, including discussion of bottom-up versus top-down approaches.

147
Organizing the Mess: Designing Decision Solutions That Matter
Presented by Steve Mack (Whitney, Bradley & Brown) at 2004 DAAG Conference in San Francisco. Discussion of organizationally complex decisions and the use of good framing and collaboration processes to work through the mess.

148
Pharmaceutical Portfolio Management
Presented by Kazuo Ezawa (BristolMyersSquibb) at 2004 DAAG Conference in San Francisco. Discussion of pharmaceutical industry challenges and how those challenges are dealt with in portfolio planning and analysis.

149
A Quick Decision Analysis Process for Selected Environmental Management Decisions
Presented by Karen Streich (Chevron) and James Mitchell (Decision Strategies) at 2004 DAAG Conference in San Francisco. Example of process and tools used to perform quick analyses of environmental problems.

150
Strategy Evaluation for a Pharmaceutical Oncology Asset
Presented by Erik C. Johnson (BristolMyersSquibb) at 2004 DAAG Conference in San Francisco. Case study of decision analysis of oncology drug development, and the unique characteristics of evaluating these types of drugs.

387
Effectively Communicating the Benefits of Decision Analysis to Executives
Presented by Jennie Rice (MDM Consulting) at 2003 DAAG Conference in Houston. This talk summarizes the results of surveys of executives on the use of DA (or lack of use).

384
A Structured Process for Developing a Performance Confirmation Plan for the Yucca Mountain Nuclear Repository
Presented by Tim Nieman (Geomatrix Consultants) at 2003 DAAG Conference in Houston. This talk discusses the use of multi-criteria concepts to develop a portfolio of performance confirmation activities.

385
Application of Attrition to Resource Forecasts
Presented by Bill Reid (GlaxoSmithKline) at 2003 DAAG Conference in Houston. This talk discusses a method of accounting for attrition in portfolio planning which uses information normally readily available and models attrition the way it happens.

386
Use of a DA Process to Develop a Petroleum Upstream Fiscal and Regulatory Regime
Presented by Tony Kenck (ChevronTexaco) at 2003 DAAG Conference in Houston. This talk discusses the failed attempt to use DA framing to negotiate fiscal terms, and lessons learned.

Stay connected